RxSight Newsroom

BTIG Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $59

Futu NewsSep 23 18:31

Needham Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $66

Futu NewsSep 13 19:33

RxSight's Growth Trajectory: A Buy Recommendation on Strong Revenue Prospects and International Expansion

TipRanksSep 13 18:38

Morgan Stanley Maintains RxSight(RXST.US) With Buy Rating, Maintains Target Price $70

Futu NewsSep 5 19:34

Needham Maintains Buy on RxSight, Raises Price Target to $66

BenzingaAug 21 00:27

RxSight Analyst Ratings

BenzingaAug 21 00:25

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS) and RxSight (RXST)

TipRanksAug 20 18:37

Needham Maintains RxSight(RXST.US) With Buy Rating, Raises Target Price to $66

Futu NewsAug 20 18:31

Oppenheimer Maintains RxSight(RXST.US) With Buy Rating, Cuts Target Price to $65

Futu NewsAug 6 21:32

A Quick Look at Today's Ratings for RxSight(RXST.US), With a Forecast Between $54 to $70

Futu NewsAug 6 21:01

Oppenheimer Adjusts RxSight Price Target to $65 From $72, Maintains Outperform Rating

MT NewswiresAug 6 20:35

RxSight Price Target Cut to $65.00/Share From $70.00 by Stifel

Dow JonesAug 6 19:44

Wells Fargo Reaffirms Their Buy Rating on RxSight (RXST)

TipRanksAug 6 19:05

Buy Rating Affirmed for RxSight Amidst Robust Growth and Market Expansion

TipRanksAug 6 18:19

RxSight Analyst Ratings

BenzingaAug 6 18:11

RxSight (RXST) Gets a Buy From Morgan Stanley

TipRanksJul 16 20:59

RxSight Analyst Ratings

BenzingaJul 16 00:57

BTIG Maintains Buy on RxSight, Raises Price Target to $73

BenzingaJul 16 00:57

Stifel Adjusts Price Target on RxSight to $70 From $75, Maintains Buy Rating

MT NewswiresJul 10 22:17

RxSight Analyst Ratings

BenzingaJul 10 21:27